The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Case Report
Does Gitelman syndrome really save bone?
Gitelman syndrome is a renal tubular disease characterized by hypokalemia, hypomagnesemia and hypocalciuria. It has been suggested that Gitelman syndrome may affect bone metabolism by different mechanisms. This case report discusses a young male patient with chronic hypomagnesemia, recurrent fractures, and osteopenia due to Gitelman syndrome.

1. Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HW.Mutations in the chloride channel gene, CLCNKB, leading to a mixedBartter-Gitelman phenotype. Pediatr Res. 2000;48(6):754-758.
2. Hsu YJ, Yang SS, Cheng CJ, et al. Thiazide-sensitive Na+ -Cl-cotransporter (NCC) gene inactivation results in increased duodenalCa2+ absorption, enhanced osteoblast differentiation and elevatedbone mineral density. J Bone Miner Res. 2015;30(1):116-127.
3. Qi W, Yin Z, Liang H, et al. Na-Cl Co-transporter (NCC) geneinactivation is associated with improved bone microstructure.Osteoporos Int. 2022;33(10):2193-2204.
4. Nicolet-Barousse L, Blanchard A, Roux C, et al. Inactivation of the Na-Cl co-transporter (NCC) gene is associated with high BMD throughboth renal and bone mechanisms: analysis of patients with Gitelmansyndrome and Ncc null mice. J Bone Miner Res. 2005;20(5):799-808.
5. Nakamura A, Shimizu C, Nagai S, et al. A rare case of Gitelman’s syndromepresenting with hypocalcemia and osteopenia. J Endocrinol Invest.2005;28(5):464-468.
6. Wan X, Perry J, Zhang H, et al. Heterozygosity for a pathogenicvariant in SLC12A3 that causes autosomal recessive gitelmansyndrome is associated with lower serum potassium. J Am Soc Nephrol.2021;32(3):756-765.
7. Gennari L, Bilezikian JP. Osteoporosis in men. Endocrinol Metab Clin North Am.2007;36(2):399-419.
8. Cesareo R, Iozzino M, D’onofrio L, et al. Effectiveness and safety ofcalcium and vitamin D treatment for postmenopausal osteoporosis.Minerva Endocrinol. 2015;40(3):231-237.
9. Rude RK. Magnesium homeostasis. In: Bilezikian JP, Raisz LG, MartinTJ, eds. Principles of Bone Biology. 3rd ed. Academic Press: 2008:487-513.
10. Tucker KL, Hannan MT, Kiel DP. The acid-base hypothesis: diet and bonein the Framingham Osteoporosis Study. Eur J Nutr. 2001;40(5):231-237.
11. Castiglioni S, Cazzaniga A, Albisetti W, Maier JA. Magnesium andosteoporosis: current state of knowledge and future research directions.Nutrients. 2013;5(8):3022-3033.
12. Bigi A, Foresti E, Gregorini R, Ripamonti A, Roveri N, Shah JS. The roleof magnesium on the structure of biological apatites. Calcif Tissue Int.1992;50(5):439-444.
Volume 2, Issue 1, 2024
Page : 26-28